CKD-828 S-Amlodipine Non-Responder Trial
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 187 participants.
Also called NCT01501253
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 187 participants
- Registry
-
NCT01501253
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT01501253. Randomized; triple masking; primary purpose treatment. Start 2011-08 (registry gives no type); primary completion 2012-09 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- CKD-828 S-Amlodipine Non-Responder Trial
- Condition
- Hypertension
- Intervention (Drug)
- CKD-828 2.5/40mg
- Intervention (Drug)
- CKD-828 2.5/80mg
- Intervention (Drug)
- S-Amlodipine 2.5mg
- Lead sponsor
- Chong Kun Dang Pharmaceutical
Record details
- Record id
cardio:ct-nct01501253- Content hash
927daf08177ec9ceaee7af00e5d750a9e3909ff10cb0084db1efc13fa4289c93